Leukemia, myeloid, acute
Clinical trials for Leukemia, myeloid, acute explained in plain language.
Never miss a new study
Get alerted when new Leukemia, myeloid, acute trials appear
Sign up with your email to follow new studies for Leukemia, myeloid, acute, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for Tough-to-Treat leukemia: experimental drug DFP-10917 tested in Late-Stage trial
Disease control Stopped earlyThis study tested a new drug called DFP-10917 in adults with acute myeloid leukemia (AML) that had returned or not responded after 2 to 4 prior treatments. Participants received either DFP-10917 or one of several standard chemotherapy combinations. The goal was to see if DFP-1091…
Matched conditions: LEUKEMIA, MYELOID, ACUTE
Phase 3 • Sponsor: Delta-Fly Pharma, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Experimental leukemia drug trial halted early
Disease control Stopped earlyThis early-stage study tested a new drug called CC-95251, alone or with other cancer drugs, in people with acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS) that had come back or not responded to treatment. The main goals were to check safety and find the right dose…
Matched conditions: LEUKEMIA, MYELOID, ACUTE
Phase 1 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC